MSD Invents is a leading brand that is dedicated to advancing research and development efforts in the field of medicine. With a strong commitment to making a meaningful impact on the COVID-19 pandemic, MSD is focused on developing an investigational oral antiviral COVID-19 medicine. In collaboration with Ridgeback Biotherapeutics, they have made significant progress in their research and development endeavors.

MSD is actively working with health authorities to ensure global access to their oral antiviral treatment. In addition to their COVID-19 efforts, MSD has a long-standing track record of making their medicines and vaccines accessible and affordable. They have implemented a comprehensive supply and access strategy, which includes agreements with governments and voluntary licensing agreements with generic manufacturers to ensure their treatment options are available to patients worldwide, including in low- and middle-income countries.

MSD Invents continues to prioritize the health, safety, and well-being of their employees and communities during the pandemic. Their commitment to combating COVID-19 extends beyond their research efforts, as they actively support healthcare providers and communities through volunteer and donation efforts